Table of Contents 2
List of Tables 4
List of Figures 4
Genmab A/S Spshot 5
Genmab A/S Overview 5
Key Information 5
Key Facts 5
Genmab A/S - Research and Development Overview 6
Key Therapeutic Areas 6
Genmab A/S - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Partnered Products 11
Partnered Products/Combition Treatment Modalities 12
Pipeline Products - Out-Licensed Products 13
Out-Licensed Products/Combition Treatment Modalities 14
Genmab A/S - Pipeline Products Glance 15
Genmab A/S - Clinical Stage Pipeline Products 15
Phase II Products/Combition Treatment Modalities 15
Phase I Products/Combition Treatment Modalities 16
Genmab A/S - Early Stage Pipeline Products 17
Preclinical Products/Combition Treatment Modalities 17
Genmab A/S - Drug Profiles 18
teprotumumab 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
tisotumab vedotin 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
HuMax-AXL-ADC 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
IDD-004 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Monoclol Antibody 1 for Central Nervous System Disorders 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Monoclol Antibody 2 for Central Nervous System Disorders 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Monoclol Antibody 3 for Central Nervous System Disorders 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Mononclol Antibody 1 for Oncology 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Mononclol Antibody 2 for Oncology 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Mononclol Antibody Conjugate for Oncology 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Genmab A/S - Pipeline Alysis 31
Genmab A/S - Pipeline Products by Target 31
Genmab A/S - Pipeline Products by Route of Administration 32
Genmab A/S - Pipeline Products by Molecule Type 33
Genmab A/S - Pipeline Products by Mechanism of Action 34
Genmab A/S - Recent Pipeline Updates 35
Genmab A/S - Dormant Projects 37
Genmab A/S - Discontinued Pipeline Products 38
Discontinued Pipeline Product Profiles 38
HuMax-CD74-ADC 38
teprotumumab 38
Genmab A/S - Company Statement 39
Genmab A/S - Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Appendix 42
Methodology 42
Coverage 42
Secondary Research 42
Primary Research 42
Expert Panel Validation 42
Contact Us 42
Disclaimer 43